HU218947B - Metabolikus csontbetegség kezelésére szolgáló humán Il-1R proteint tartalmazó gyógyszerkészítmények - Google Patents

Metabolikus csontbetegség kezelésére szolgáló humán Il-1R proteint tartalmazó gyógyszerkészítmények Download PDF

Info

Publication number
HU218947B
HU218947B HU9501779A HU9501779A HU218947B HU 218947 B HU218947 B HU 218947B HU 9501779 A HU9501779 A HU 9501779A HU 9501779 A HU9501779 A HU 9501779A HU 218947 B HU218947 B HU 218947B
Authority
HU
Hungary
Prior art keywords
ile
lys
leu
protein
glu
Prior art date
Application number
HU9501779A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9501779D0 (en
HUT72054A (en
Inventor
Masakazu Katoh
Kazuyuki Kitamura
Original Assignee
Hoechst Japan Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd. filed Critical Hoechst Japan Ltd.
Publication of HU9501779D0 publication Critical patent/HU9501779D0/hu
Publication of HUT72054A publication Critical patent/HUT72054A/hu
Publication of HU218947B publication Critical patent/HU218947B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9501779A 1994-06-17 1995-06-16 Metabolikus csontbetegség kezelésére szolgáló humán Il-1R proteint tartalmazó gyógyszerkészítmények HU218947B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6135275A JPH083058A (ja) 1994-06-17 1994-06-17 新規な骨代謝疾患治療剤

Publications (3)

Publication Number Publication Date
HU9501779D0 HU9501779D0 (en) 1995-08-28
HUT72054A HUT72054A (en) 1996-03-28
HU218947B true HU218947B (hu) 2001-01-29

Family

ID=15147903

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501779A HU218947B (hu) 1994-06-17 1995-06-16 Metabolikus csontbetegség kezelésére szolgáló humán Il-1R proteint tartalmazó gyógyszerkészítmények

Country Status (10)

Country Link
US (1) US5726148A (fi)
EP (1) EP0687470A3 (fi)
JP (1) JPH083058A (fi)
KR (1) KR960000248A (fi)
AU (1) AU697136B2 (fi)
CA (1) CA2152023A1 (fi)
FI (1) FI952953A (fi)
HU (1) HU218947B (fi)
NO (1) NO952411L (fi)
TW (1) TW496740B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
JP3755564B2 (ja) 1999-05-24 2006-03-15 株式会社村田製作所 圧電共振部品及びその製造方法
CN101850120A (zh) 1999-07-21 2010-10-06 奥默罗斯公司 用于抑制疼痛,炎症和软骨退化的溶液及方法
US20050074434A1 (en) * 2001-02-23 2005-04-07 Tomoaki Hoshino Remedies for metabolic bone diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
AU6030990A (en) * 1989-07-07 1991-02-06 E.I. Du Pont De Nemours And Company Soluble human b-cell interleukin-1 receptor
DE69116772T2 (de) * 1990-09-03 1996-07-25 Kuraray Co Peptid oder seine Salze
EP0563239A4 (en) * 1990-12-20 1994-10-12 Univ Pittsburgh A truncated interleukin-1 receptor gene for the treatment of arthritis.

Also Published As

Publication number Publication date
EP0687470A2 (en) 1995-12-20
FI952953A0 (fi) 1995-06-15
NO952411D0 (no) 1995-06-16
HU9501779D0 (en) 1995-08-28
US5726148A (en) 1998-03-10
FI952953A (fi) 1995-12-18
AU2171695A (en) 1996-01-04
EP0687470A3 (en) 1996-06-19
NO952411L (no) 1995-12-18
HUT72054A (en) 1996-03-28
CA2152023A1 (en) 1995-12-18
AU697136B2 (en) 1998-09-24
KR960000248A (ko) 1996-01-25
TW496740B (en) 2002-08-01
JPH083058A (ja) 1996-01-09

Similar Documents

Publication Publication Date Title
KR101997757B1 (ko) 악액질 예방 또는 치료용 조성물
EP2937088B1 (en) Composition having tissue repairing activity and utilization thereof
CA2332817A1 (en) Il-6 antagonist peptides
JP2021505611A (ja) 免疫疾患の予防または治療のためのｒｉｐｋ１阻害剤とｉｋｋ阻害剤の組み合わせ
US20060188476A1 (en) Interleukin 20 (IL-20) and its use in neovascularisation
US20170128525A1 (en) Administration of Angiocidin for the Treatment of Cancer
US7208469B2 (en) Therapeutic method
HU218947B (hu) Metabolikus csontbetegség kezelésére szolgáló humán Il-1R proteint tartalmazó gyógyszerkészítmények
CA2587061A1 (en) Deamidated interferon-beta
TWI818286B (zh) 包括表現腫瘤壞死因子可誘導基因６的間葉幹細胞之組成物及藥物組成物
US6255283B1 (en) Use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF)
US7776818B2 (en) Methods to treat T-cell disorders using TISF
WO2021096217A1 (ko) 재조합 안정화 갈렉틴 9 단백질을 포함하는 류마티스 관절염 및 골질환 예방 또는 치료용 약학적 조성물
US5462731A (en) Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas
US7232796B2 (en) Medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteoanabolically active substance
WO2024122720A1 (ko) 연골 재생용 펩타이드 및 이의 용도
WO2024122721A1 (ko) 연골 재생용 펩타이드 및 이의 용도
KR101169850B1 (ko) 트로락스를 포함하는 골 대사성 질환 또는 골 전이성 암 질환 예방 및 치료용 약제학적 조성물
WO2024122718A1 (ko) 연골 재생용 펩타이드 및 이의 용도
WO2024122727A1 (ko) 연골 재생용 펩타이드 및 이의 용도
US20240358790A1 (en) Compositions and methods for treating autoimmunity, including autoimmunity associated with cancer and cancer therapy
US20210113652A1 (en) Maspin-based inhibition of osteoclast activity and promotion of bone formation
JP2008519032A (ja) Ｆｇｆ−２０の調合物、生成方法および使用
JP2000229880A (ja) 骨形成促進剤
AU2003273758A1 (en) Treatment of allergic conditions by use of il 21

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee